191 related articles for article (PubMed ID: 37038335)
1. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors.
Brown AL; Sok P; Raghubar KP; Lupo PJ; Richard MA; Morrison AC; Yang JJ; Stewart CF; Okcu MF; Chintagumpala MM; Gajjar A; Kahalley LS; Conklin H; Scheurer ME
Neuro Oncol; 2023 Sep; 25(9):1698-1708. PubMed ID: 37038335
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors.
Pulsifer MB; Duncanson H; Grieco J; Evans C; Tseretopoulos ID; MacDonald S; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):391-398. PubMed ID: 30108004
[TBL] [Abstract][Full Text] [Related]
3. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors.
Mizumoto M; Oshiro Y; Pan H; Wang F; Kaste SC; Gajjar A; Chemaitilly W; Merchant TE
Pediatr Blood Cancer; 2020 Oct; 67(10):e28617. PubMed ID: 32715632
[TBL] [Abstract][Full Text] [Related]
4. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.
Kahalley LS; Douglas Ris M; Mahajan A; Fatih Okcu M; Chintagumpala M; Paulino AC; Whitehead WE; Minard CG; Stancel HH; Orobio J; Xue JJ; Warren EA; Grosshans DR
Neuro Oncol; 2019 Jun; 21(6):809-818. PubMed ID: 30753584
[TBL] [Abstract][Full Text] [Related]
5. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.
Pulsifer MB; Sethi RV; Kuhlthau KA; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):400-7. PubMed ID: 26254679
[TBL] [Abstract][Full Text] [Related]
6. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
Hiniker SM; Agarwal R; Modlin LA; Gray CC; Harris JP; Million L; Kiamanesh EF; Donaldson SS
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):67-74. PubMed ID: 24725690
[TBL] [Abstract][Full Text] [Related]
7. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
[TBL] [Abstract][Full Text] [Related]
8. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches.
Moxon-Emre I; Dahl C; Ramaswamy V; Bartels U; Tabori U; Huang A; Cushing SL; Papaioannou V; Laperriere N; Bouffet E; Mabbott DJ
Cancer Med; 2021 Oct; 10(20):7111-7125. PubMed ID: 34480430
[TBL] [Abstract][Full Text] [Related]
9. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.
Merchant TE; Kiehna EN; Li C; Shukla H; Sengupta S; Xiong X; Gajjar A; Mulhern RK
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):210-21. PubMed ID: 16472938
[TBL] [Abstract][Full Text] [Related]
10. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy.
Roth AK; Ris MD; Orobio J; Xue J; Mahajan A; Paulino AC; Grosshans D; Okcu MF; Chintagumpala M; Kahalley LS
Pediatr Blood Cancer; 2020 Feb; 67(2):e28064. PubMed ID: 31736188
[TBL] [Abstract][Full Text] [Related]
11. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
12. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.
Kahalley LS; Peterson R; Ris MD; Janzen L; Okcu MF; Grosshans DR; Ramaswamy V; Paulino AC; Hodgson D; Mahajan A; Tsang DS; Laperriere N; Whitehead WE; Dauser RC; Taylor MD; Conklin HM; Chintagumpala M; Bouffet E; Mabbott D
J Clin Oncol; 2020 Feb; 38(5):454-461. PubMed ID: 31774710
[TBL] [Abstract][Full Text] [Related]
13. Utility of the General Ability Index (GAI) and Cognitive Proficiency Index (CPI) with survivors of pediatric brain tumors: Comparison to Full Scale IQ and premorbid IQ estimates.
Kahalley LS; Winter-Greenberg A; Stancel H; Ris MD; Gragert M
J Clin Exp Neuropsychol; 2016 Dec; 38(10):1065-76. PubMed ID: 27295192
[TBL] [Abstract][Full Text] [Related]
14. Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.
Gross JP; Powell S; Zelko F; Hartsell W; Goldman S; Fangusaro J; Lulla RR; Smiley NP; Chang JH; Gondi V
Neuro Oncol; 2019 Jul; 21(7):934-943. PubMed ID: 30997512
[TBL] [Abstract][Full Text] [Related]
15. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors.
Kahalley LS; Ris MD; Grosshans DR; Okcu MF; Paulino AC; Chintagumpala M; Moore BD; Guffey D; Minard CG; Stancel HH; Mahajan A
J Clin Oncol; 2016 Apr; 34(10):1043-9. PubMed ID: 26811522
[TBL] [Abstract][Full Text] [Related]
16. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor.
Heitzer AM; Villagran AM; Raghubar K; Brown AL; Camet ML; Ris MD; Hanning JH; Okcu MF; Paulino AC; Chintagumpala M; Kahalley LS
J Neurooncol; 2020 Jan; 146(1):147-156. PubMed ID: 31782051
[TBL] [Abstract][Full Text] [Related]
17. Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
Ebadi M; Morse M; Gooley T; Ermoian R; Halasz LM; Lo SS; Yang JT; Blau MH; Percival ME; Cassaday RD; Graber J; Taylor LP; Venur V; Tseng YD
J Neurooncol; 2024 Jan; 166(2):351-357. PubMed ID: 38244173
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study across pediatric central nervous system tumors implicates shared predisposition and points to 1q25.2 (PAPPA2) and 11p12 (LRRC4C) as novel candidate susceptibility loci.
Foss-Skiftesvik J; Hagen CM; Mathiasen R; Adamsen D; Bækvad-Hansen M; Børglum AD; Nordentoft M; Werge T; Christiansen M; Schmiegelow K; Juhler M; Mortensen PB; Hougaard DM; Bybjerg-Grauholm J
Childs Nerv Syst; 2021 Mar; 37(3):819-830. PubMed ID: 33226468
[TBL] [Abstract][Full Text] [Related]
19. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study.
Brinkman TM; Krasin MJ; Liu W; Armstrong GT; Ojha RP; Sadighi ZS; Gupta P; Kimberg C; Srivastava D; Merchant TE; Gajjar A; Robison LL; Hudson MM; Krull KR
J Clin Oncol; 2016 Apr; 34(12):1358-67. PubMed ID: 26834063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]